BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10156145)

  • 1. Managed care will end era of provider networks.
    Ricks CS
    Mod Healthc; 1996 Mar; 26(13):92. PubMed ID: 10156145
    [No Abstract]   [Full Text] [Related]  

  • 2. Managed care. Can doctor plans compete with the big boys?
    Murray D
    Med Econ; 1994 Dec; 71(23):134-40. PubMed ID: 10138864
    [No Abstract]   [Full Text] [Related]  

  • 3. The power and potential of capitation.
    Boland P
    Manag Care Q; 1997; 5(1):1-9. PubMed ID: 10164643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic considerations for provider sponsored organizations entering the risk-bearing Medicare market.
    Treash M; Thomson K
    Manag Care Q; 1997; 5(4):43-7. PubMed ID: 10175719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positioning PCNs (primary care networks): understand what MCOs really want.
    Holm CE; Zuza DJ
    Health Care Strateg Manage; 1997 Aug; 15(8):1, 22-3. PubMed ID: 10169037
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond the gatekeeper: managed care evolves.
    Droste TM
    Med Netw Strategy Rep; 1997 Feb; 6(2):1-6. PubMed ID: 10164830
    [No Abstract]   [Full Text] [Related]  

  • 7. The dynamics of market reform.
    Integr Healthc Rep; 1994 Apr; ():1-13. PubMed ID: 10134339
    [No Abstract]   [Full Text] [Related]  

  • 8. Managed care 1998: Medicare managed care. PSOs: success isn't guaranteed.
    Rice B
    Med Econ; 1998 Mar; 75(6):83-4, 89-90, 95. PubMed ID: 10177634
    [No Abstract]   [Full Text] [Related]  

  • 9. The survival and prosperity of physician-led networks.
    Krohn R
    Cost Qual Q J; 1998 Jun; 4(2):33-6. PubMed ID: 10182597
    [No Abstract]   [Full Text] [Related]  

  • 10. A practical approach for analyzing antitrust issues faced by provider networks.
    Ross DC
    J Health Hosp Law; 1997; 30(3):133-45. PubMed ID: 10179111
    [No Abstract]   [Full Text] [Related]  

  • 11. When you look in your crystal ball, do you see a PSO in your future?
    Manag Care Strateg; 1998 May; 6(5):49-51. PubMed ID: 10181767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The managed care time clock: what's making it tick?
    Beck DF; Dempsy J
    Health Care Superv; 1996 Mar; 14(3):1-12. PubMed ID: 10154915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storm warning. Insurance regulation.
    Health Syst Rev; 1995; 28(5):26-9, 32-7. PubMed ID: 10152467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs in check, but competition will erode capitation margins.
    Capitation Rates Data; 1998 Mar; 3(3):34-6. PubMed ID: 10345859
    [No Abstract]   [Full Text] [Related]  

  • 15. Competitive and strategic positioning of national clinical reference laboratories in response to managed care.
    Cortest L; Kissel E
    Clin Lab Manage Rev; 1996; 10(5):545-50. PubMed ID: 10162019
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing readiness for PSOs?
    Cochrane JD
    Integr Healthc Rep; 1997 Aug; ():4-10. PubMed ID: 10176572
    [No Abstract]   [Full Text] [Related]  

  • 17. Competitive market analysis can reveal your core costs.
    Capitation Manag Rep; 1999 Jul; 6(7):111-2, 97. PubMed ID: 10539518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capitation survival kit: how to fashion provider excess coverage.
    Paige L; Crain E; Bollman J
    J Healthc Risk Manag; 1997; 17(2):19-26. PubMed ID: 10170195
    [No Abstract]   [Full Text] [Related]  

  • 19. Is your organization's market ready for a Medicare PSO?
    Fried I
    Healthc Financ Manage; 1998 Jul; 52(7):48-50. PubMed ID: 10180894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conversation with Alan Hoops.
    Hoops A
    Med Interface; 1997 Jan; 10(1):59-61, 65. PubMed ID: 10164506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.